Article Contents ::
- 1 Details About Generic Salt :: Mephente
- 2 Main Medicine Class:: Vasopressor
- 3 (meh-FEN-ter-meen SULL-fate) Wyamine Sulfate Class: Vasopressor
- 4 Drugs Class ::
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
Details About Generic Salt :: Mephente
Main Medicine Class:: Vasopressor
(meh-FEN-ter-meen SULL-fate)
Wyamine Sulfate
Class: Vasopressor
Drugs Class ::
Action Acts directly and indirectly (via release of norepinephrine) on beta and alpha receptors, causing increase in cardiac contraction and, to lesser degree, increase in peripheral vasoconstriction.
Indications for Drugs ::
Indications Treatment of hypotension secondary to ganglionic blockade and to spinal anesthesia; maintenance of blood pressure until blood or blood substitutes may be administered during hypovolemic shock.
Drug Dose ::
Route/Dosage
Shock and Hypotension
ADULTS: IM 0.5 mg/kg undiluted. IV 1 mg/ml solution in D5W titrated to clinical response.
Hypotension Following Spinal Anesthesia
ADULTS: IV 30–45 mg; repeat doses of 30 mg prn; or give as 1 mg/ml infusion in D5W titrated to clinical response.
Prevention of Hypotension Following Spinal Anesthesia
ADULTS: IM 30–45 mg 10–20 min prior to anesthesia, operation or termination of operative procedure.
Hypotension Secondary to Spinal Anesthesia During Cesarean Section
ADULTS: IV 15 mg; repeat prn.
Hemorrhagic Shock
ADULTS: IV Continuous infusion of 1 mg/ml solution in D5W until whole blood replacement can be accomplished.
Contraindication ::
Contraindications Hypotension induced by chlorpromazine; use of MAO inhibitors.
Drug Precautions ::
Precautions
Pregnancy: Category C. Lactation: Undetermined. Cardiovascular effects: May be profound. Use with caution in chronically ill patients and patients with known cardiovascular disease or hyperthyroidism. Hypovolemia: Avoid in patients with uncorrected hypovolemia. Persistent hypotension may indicate hypovolemia.
PATIENT CARE CONSIDERATIONS |
|
Drug Side Effects ::
Adverse Reactions
CV: Cardiac arrhythmias; excessive hypertension, especially in patients with heart disease. CNS: Anxiety; seizures.
Drug Mode of Action ::
Action Acts directly and indirectly (via release of norepinephrine) on beta and alpha receptors, causing increase in cardiac contraction and, to lesser degree, increase in peripheral vasoconstriction.
Drug Interactions ::
Interactions
Guanethidine: Antihypertensive effects of guanethidine may be negated. Halogenated hydrocarbon anesthetics: May sensitize myocardium to arrhythmogenic effects of catecholamines. MAO inhibitors, furazolidone, rauwolfia alkaloids, methyldopa: May significantly increase pressor response, possibly resulting in hypertensive crisis and intracranial hemorrhage. Oxytoxic drugs: Synergistic or additive vasoconstrictive effects may occur, resulting in hypertension and possible gangrene in the extremities. Tricyclic antidepressants: May decrease pressor response.
Drug Assesment ::
Assessment/Interventions
- Obtain patient history, including drug history and any known allergies.
- Use electronic infusion device for IV administration.
- Monitor I&O. If urinary output is < 30 ml/hr, notify physician.
- Monitor BP during IV administration and every 5 min after IM administration.
|
Drug Storage/Management ::
Administration/Storage
- If solution is discolored, do not use; discard.
- IV solution can be prepared by adding 10 or 20 ml of 30 mg/ml mephentermine to 250 ml or 500 ml of D5W, respectively.
- Store reconstituted solution no longer than 24 hr.
Drug Notes ::
Patient/Family Education
- Instruct patient and family to notify physician if any otc cold or allergy preparation has been used within 3 days of surgery.
- Inform physician of use of MAO inhibitors or tricyclic antidepressants within 1 mo of surgery.